138 related articles for article (PubMed ID: 11000989)
1. Autologous peripheral blood stem cell transplantation for acute leukaemias.
de la Rubia J; Sanz MA
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):139-50. PubMed ID: 11000989
[TBL] [Abstract][Full Text] [Related]
2. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
[TBL] [Abstract][Full Text] [Related]
4. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival.
de la Rubia J; Sanz GF; Martín G; Martínez J; Cervera J; Solves P; Jiménez C; Arnao M; Vicente A; Jarque I; Sempere A; Sanz MA
Haematologica; 1999 Feb; 84(2):125-32. PubMed ID: 10091410
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S
Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189
[TBL] [Abstract][Full Text] [Related]
6. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution.
Sanz MA; de la Rubia J; Sanz GF; Martín G; Martínez J; Jarque I; Sempere A; Gomis F; Senent L; Soler MA
J Clin Oncol; 1993 Sep; 11(9):1661-7. PubMed ID: 8102640
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
[TBL] [Abstract][Full Text] [Related]
8. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
Visani G; Lemoli RM; Isidori A; Piccaluga PP; Martinelli G; Malagola M; Gugliotta L; Bonini A; Bonifazi F; Motta MR; Rizzi S; Castellani S; Tura S
Bone Marrow Transplant; 2001 Apr; 27(8):829-35. PubMed ID: 11477440
[TBL] [Abstract][Full Text] [Related]
9. Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.
Archimbaud E; Jehn U; Thomas X; De Cataldo F; Fillet G; Belhabri A; Peaud PY; Martin C; Amadori S; Willemze R
Leukemia; 1999 Jun; 13(6):843-9. PubMed ID: 10360370
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
11. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia.
Gondo H; Harada M; Miyamoto T; Takenaka K; Tanimoto K; Mizuno S; Fujisaki T; Nagafuji K; Hayashi S; Eto T; Taniguchi S; Akashi K; Harada N; Yamasaki K; Shibuya T; Matsuishi E; Ohno Y; Makino S; Takamatsu Y; Murakawa M; Teshima T; Hirota Y; Okamura T; Kinukawa N; Niho Y
Bone Marrow Transplant; 1997 Nov; 20(10):821-6. PubMed ID: 9404921
[TBL] [Abstract][Full Text] [Related]
12. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD
Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
[TBL] [Abstract][Full Text] [Related]
13. [Autologous blood stem cell transplantation-current status and issues. Fukuoka Bone Marrow Transplantation Group].
Nagafuji K; Harada M
Rinsho Ketsueki; 1995 Jun; 36(6):530-7. PubMed ID: 7643446
[TBL] [Abstract][Full Text] [Related]
14. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome.
Martín C; Torres A; León A; Rubio V; Alvarez MA; Herrera C; Jean-Paul E; Correa MA; Rojas R; Campos R; Serrano J; Romero R; Román J; Guzmán JL; Flores R; Falcón M; Martínez F; Gómez P
Bone Marrow Transplant; 1998 Feb; 21(4):375-82. PubMed ID: 9509972
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation for acute myeloid leukemia.
Imrie K; Dicke KA; Keating A
Stem Cells; 1996 Jan; 14(1):69-78. PubMed ID: 8820953
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation for acute myeloid leukemia.
Linker CA
Bone Marrow Transplant; 2003 May; 31(9):731-8. PubMed ID: 12732879
[TBL] [Abstract][Full Text] [Related]
17. New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients.
Bruserud O; Tjønnfjord G; Gjertsen BT; Foss B; Ernst P
Stem Cells; 2000; 18(5):343-51. PubMed ID: 11007918
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood stem cell collection after intermediate-dose cytarabine in adult patients with acute myeloblastic leukemia undergoing autologous blood stem cell transplantation in first complete remission.
de la Rubia J; Martín G; Martínez J; Lorenzo I; Sanz G; Jarque I; Moscardó F; Jiménez C; Lorente P; Camps A; Sanz MA
Int J Hematol; 2004 Aug; 80(2):168-73. PubMed ID: 15481447
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients.
Visani G; Lemoli RM; Tosi P; Martinelli G; Testoni N; Ricci P; Piccaluga PP; Pastano R; Leopardi G; Dizdari A; Motta MR; Rizzi S; Tura S
Br J Haematol; 1999 Jun; 105(3):775-9. PubMed ID: 10354146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
